Literature DB >> 31480039

Coronary Artery Disease Assessed by Computed Tomography in Patients with Psoriasis: A Systematic Review and Meta-Analysis.

Hannah Kaiser1, Jawdat Abdulla2, Kristoffer M A Henningsen3, Lone Skov4,5, Peter Riis Hansen3,5.   

Abstract

BACKGROUND: Patients with psoriasis have an increased risk of coronary artery disease (CAD) but data on coronary calcium score (CCS) and cardiac computed tomography angiography (CCTA) are inconsistent.
OBJECTIVES: The present study quantitatively summarizes the literature data on the prevalence and burden of CAD in patients with psoriasis compared with controls using CCS and CCTA.
METHODS: A systematic review and meta-analysis was conducted. The search included all studies examining CAD prevalence and burden detected by CCS with or without CCTA in patients with psoriasis without prior CAD compared with controls, between the year 2000 and May 30, 2018.
RESULTS: Fourteen eligible studies provided data on 1,427 patients with psoriasis and 9,670 controls. Pooled data provided the estimated risk ratio (RR) of CAD and weighted mean differences of CCS in psoriasis patients versus controls. Meta-analysis of the prevalence and burden of CCS showed that patients with psoriasis had an increased risk of CAD (RR 1.14, 95% CI 1.04-1.26; p = 0.004), and for more severe CAD (CCS >100) the risk was further increased (RR 1.71, 95% CI 1.28-2.30; p < 0.001) compared with controls. Weighted mean difference for CCS was significantly higher in patients with psoriasis (12.74, 95% CI 10.70-14.78; p < 0.001). The risk of high-risk coronary plaques identified by CCTA was also significantly higher in psoriasis patients compared with controls (RR 1.77, 95% CI 1.37-2.28; p < 0.001).
CONCLUSIONS: Patients with psoriasis have a higher prevalence of subclinical CAD, a higher burden of the disease, and more high-risk coronary plaques compared with controls without psoriasis.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Coronary calcium score; Coronary computed tomography; High-risk plaque; Psoriasis

Mesh:

Substances:

Year:  2019        PMID: 31480039     DOI: 10.1159/000502138

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  10 in total

Review 1.  Chronic inflammatory diseases, myocardial function and cardioprotection.

Authors:  Antigone Lazou; Ignatios Ikonomidis; Monika Bartekova; Theodora Benedek; George Makavos; Dimitra Palioura; Hector Cabrera Fuentes; Ioanna Andreadou
Journal:  Br J Pharmacol       Date:  2020-02-08       Impact factor: 8.739

Review 2.  Endothelial Dysfunction in Psoriasis: An Updated Review.

Authors:  Panagiota Anyfanti; Anastasia Margouta; Kyriakos Goulas; Maria Gavriilaki; Elizabeth Lazaridou; Aikaterini Patsatsi; Eugenia Gkaliagkousi
Journal:  Front Med (Lausanne)       Date:  2022-06-10

Review 3.  Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review.

Authors:  Jin Bu; Ruilian Ding; Liangjia Zhou; Xiangming Chen; Erxia Shen
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

Review 4.  Comorbidity in Adult Psoriasis: Considerations for the Clinician.

Authors:  Christine Daugaard; Lars Iversen; Kasper Fjellhaugen Hjuler
Journal:  Psoriasis (Auckl)       Date:  2022-06-10

Review 5.  Psoriasis and Cardiovascular Risk: A Comprehensive Review.

Authors:  Walter Masson; Martín Lobo; Graciela Molinero
Journal:  Adv Ther       Date:  2020-04-20       Impact factor: 3.845

6.  Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.

Authors:  Matthew T Patrick; Haihan Zhang; Rachael Wasikowski; Errol P Prens; Stephan Weidinger; Johann E Gudjonsson; James T Elder; Kevin He; Lam C Tsoi
Journal:  J Allergy Clin Immunol       Date:  2021-01-21       Impact factor: 14.290

7.  Atherosclerosis attacks in patients with psoriasis vulgaris but without a relationship with the severity and course of the disease.

Authors:  Agnieszka Białecka; Marcin Białecki; Zbigniew Serafin; Rafał Czajkowski
Journal:  Postepy Dermatol Alergol       Date:  2021-09-17       Impact factor: 1.837

8.  Data Mining and Meta-Analysis of Psoriasis Based on Association Rules.

Authors:  Jiarui Ou; Jianglin Zhang
Journal:  J Healthc Eng       Date:  2022-01-27       Impact factor: 2.682

Review 9.  Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.

Authors:  J J Wu; A Kavanaugh; M G Lebwohl; R Gniadecki; J F Merola
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-14       Impact factor: 9.228

10.  Biomarkers of subclinical atherosclerosis in patients with psoriasis.

Authors:  Hannah Kaiser; Xing Wang; Amanda Kvist-Hansen; Martin Krakauer; Peter Michael Gørtz; Benjamin D McCauley; Lone Skov; Christine Becker; Peter Riis Hansen
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.